65,437 trials
Periodic Fevers Syndrome
Primary: Number of Participants With Non-serious Adverse Events, Serious Adverse Events and Deaths — 1; 1; 0; 0 Participants
Wild-type RAS Metastatic Colorectal Cancer
Primary: Total Number of Panitumumab Infusions — 10.0; 10.0; 8.0 infusions
Palliative Care
Primary: Hospital Site of Death: Number of Decedents Cared for in an Enrolled and Assigned NH Facility, Who Were Transferred to a Hospital and Died in the Hospital During the…
Metastatic Prostate Cancer
Primary: Measurement of Sensitivity of DCFBC-PET as Determined by Agreement of PET/CT Detection of Metastatic Prostate Cancer With Conventional Imaging Modality (CIM) — 148; 170…
Multiple Sclerosis
Primary: Change From Baseline in the Medication Satisfaction Questionnaire (MSQ) to Month 6 Using a Repeated Measures ANCOVA — 5.396; 5.717 units on a scale — p=<0.001
Essential Voice Tremor · Vocal Tremor · Voice Tremor
Primary: Magnitude of Acoustic Amplitude Tremor and Magnitude of Acoustic Frequency Tremor — 12.91; 13.49; 12.43; 9.35 percentage of voice signal with tremor — p=0.0216
Suicide
Primary: Change From Baseline in Scores on the Patient Health Questionnaire (PHQ-9) Scale at Week 6 — 19.8; 15.17; 16.86; 16.83 units on a scale
Nonsquamous Nonsmall Cell Neoplasm of Lung
Primary: To Compare the Investigator-assessed (RECIST) v1.1 Response Rate in the Treatment Arms. — 0; 0; 0; 13 Participants — p==0.0401
Lymphocytic Leukemia, Chronic
Primary: Percentage of Participants With Disease Progression (PD), Relapse, or Death Due to Any Cause Assessed According to the National Cancer Institute (NCI) Revised Guidelines…
Peripheral Nerve Facial Nerve Paralysis · Facial Nerve Diseases · Orofacial Pain
Primary: The Visual Analog Scale for Pain Was Used to Grade Discomfort in Chewing After the Installation of Facial Paralysis. Level Zero is the Lack of Discomfort and 10 is the…
Acne Vulgaris
Primary: Change in Inflammatory Lesion Counts — -58.44; -60.07; -53.28 percent change — p=0.0185
Acute Myeloid Leukemia
Primary: Number of Patients With Dose Limiting Toxicity — 0 Participants
Diabetes
Primary: Hemoglobin A1c (HbA1c) at 6 Months Post Randomization — 10.0; 9.0 percentage of glycosylated hemoglobin — p=<0.05
Pulmonary Disease, Chronic Obstructive
Primary: Trough Forced Expiratory Volume in 1 Second (FEV1) (in Liter) After 28 Days of Treatment — 1.422; 1.399 Liter — p=<0.0001
Fallopian Tube Cancer · Ovarian Cancer · Peritoneal Cancer
Primary: Feasibility of Electronic Capture of Patient-reported Symptoms From Home Following Major Gynecologic Cancer Surgery — 18; 3; 2; 1 Participants